Cancer Metastatic therapy: Glabridin (GLA) suppresses the expression of IKBKB (Inhibitor Of Kappa Light Polypeptide Gene Enhancer In B-Cells, Kinase) via up regulation of its target gene, 28/April/2014, 8.00 am

Cancer Metastatic therapy: Glabridin (GLA) suppresses the expression of IKBKB (Inhibitor Of Kappa Light Polypeptide Gene Enhancer In B-Cells, Kinase) via up regulation of its target gene, 28/April/2014, 8.00 am

Cancer Metastatic therapy: Glabridin (GLA) suppresses the expression of IKBKB (Inhibitor Of Kappa Light Polypeptide Gene Enhancer In B-Cells, Kinase) via up regulation of its target gene, 28/April/2014, 8.00 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Cancer Metastatic therapy: Glabridin (GLA) suppresses the expression of IKBKB (Inhibitor Of Kappa Light Polypeptide Gene Enhancer In B-Cells, Kinase) via up regulation of its target gene, 28/April/2014, 8.00 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Share
Start Typing